Dr. Frederick Locke, MD
Claim this profileMoffitt Cancer Center
Studies Cancer
Studies B-Cell Lymphoma
14 reported clinical trials
25 drugs studied
Area of expertise
1Cancer
CD19 positive
Stage IV
T315I positive
2B-Cell Lymphoma
CD19 positive
Affiliated Hospitals
Clinical Trials Frederick Locke, MD is currently running
CAR-T Therapy
for Acute Lymphoblastic Leukemia
This is a Phase 2 Study is to determine the efficacy and safety rate of B-Cell Acute Lymphoblastic Leukemia (B-ALL) participants in remission with minimal residual disease (MRD) after KTE-X19 CAR T-cell therapy
Recruiting1 award Phase 212 criteria
Pirtobrutinib + CAR T-cell Therapy
for Mantle Cell Lymphoma
This is a phase 2, open-label, randomized, multicenter clinical trial in patients with relapsed/refractory mantle cell lymphoma (R/R MCL) who meet the criteria for standard-of-care FDA label for CD19 CAR T-cell therapy with brexucabtagene autoleucel (brexu-cel).
Recruiting1 award Phase 24 criteria
More about Frederick Locke, MD
Clinical Trial Related3 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Frederick Locke, MD has experience with
- CD19 Targeted CAR T Cell Therapy
- Pneumococcal Conjugate Vaccine (PCV13)
- Atezolizumab
- Gamma Delta T-Cell Infusion
- Fludarabine
- Total Body Irradiation
Breakdown of trials Frederick Locke, MD has run
Cancer
B-Cell Lymphoma
Lymphoma
T-Lymphoblastic Leukemia/Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Frederick Locke, MD specialize in?
Frederick Locke, MD focuses on Cancer and B-Cell Lymphoma. In particular, much of their work with Cancer has involved CD19 positive patients, or patients who are Stage IV.
Is Frederick Locke, MD currently recruiting for clinical trials?
Yes, Frederick Locke, MD is currently recruiting for 7 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Frederick Locke, MD has studied deeply?
Yes, Frederick Locke, MD has studied treatments such as CD19 targeted CAR T Cell Therapy, Pneumococcal conjugate vaccine (PCV13), Atezolizumab.
What is the best way to schedule an appointment with Frederick Locke, MD?
Apply for one of the trials that Frederick Locke, MD is conducting.
What is the office address of Frederick Locke, MD?
The office of Frederick Locke, MD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.